share_log

Novavax | 4: Statement of changes in beneficial ownership of securities-Director MCGLYNN MARGARET G

Novavax | 4: Statement of changes in beneficial ownership of securities-Director MCGLYNN MARGARET G

諾瓦瓦克斯醫藥 | 4:持股變動聲明-董事 MCGLYNN MARGARET G
美股sec公告 ·  06/14 16:21
Moomoo AI 已提取核心訊息
On June 12, 2024, Margaret G. McGlynn, reported a completed transaction involving the acquisition of 6,670 shares of Novavax Inc (NVAX) common stock at a price of $0.00 per share. This transaction was categorized as an exercise or conversion of derivative security, conducted directly by McGlynn. Following this transaction, McGlynn's direct holdings in Novavax increased to a total of 10,470 shares. The transaction reflects a significant investment in the company by McGlynn, and it may indicate confidence in the future performance of Novavax.
On June 12, 2024, Margaret G. McGlynn, reported a completed transaction involving the acquisition of 6,670 shares of Novavax Inc (NVAX) common stock at a price of $0.00 per share. This transaction was categorized as an exercise or conversion of derivative security, conducted directly by McGlynn. Following this transaction, McGlynn's direct holdings in Novavax increased to a total of 10,470 shares. The transaction reflects a significant investment in the company by McGlynn, and it may indicate confidence in the future performance of Novavax.
2024年6月12日,瑪格麗特·G·麥克格林報告已完成一筆交易,涉及以0.00美元/股的價格收購了6,670股Novavax Inc(NVAX)普通股。此交易被分類爲衍生證券的行使或換股,由麥克格林直接進行。在此交易之後,麥克格林在Novavax中的直接持股增加至總共10,470股。此項交易反映了麥克格林對該公司的重大投資,也可能表明她信懇智能Novavax的未來業績。
2024年6月12日,瑪格麗特·G·麥克格林報告已完成一筆交易,涉及以0.00美元/股的價格收購了6,670股Novavax Inc(NVAX)普通股。此交易被分類爲衍生證券的行使或換股,由麥克格林直接進行。在此交易之後,麥克格林在Novavax中的直接持股增加至總共10,470股。此項交易反映了麥克格林對該公司的重大投資,也可能表明她信懇智能Novavax的未來業績。
声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息